| Date |
Event |
| February 2010 |
Parexel Enhances Early Phase Biomarker Capabilities Through Alliance With Proteome Sciences |
| October 2009 |
PS Biomarker Services Contract With Takeda |
| September 2009 |
Life Technologies (iTRAQ) Takes Isobaric Tandem Mass Tag License Through ThermoScientific |
| July 2009 |
Millipore Licenses Alzheimers Biomarkers |
| May 2009 |
License For Brain Damage Biomarkers |
| March 2009 |
ISO 9001:2008 Certification Awarded |
| January 2009 |
License For Lung Cancer Biomarkers |
| June 2008 |
US Patent Allowance For Isobaric Tandem Mass Tags (TMT®) |
| May 2008 |
SENS-IT-IV Framework 6 EU Grant Award |
| April 2008 |
Proteome Sciences Licenses its Patented TMT® Technology to Thermo Fisher Scientific |
| November 2007 |
Issuance of US patent for isobaric tandem mass tags® (TMT®) |
| September 2007 |
VIRxSYS Acquires Intronn Assets For Stock |
| July 2007 |
Notice of Allowance of TMT1 Patent in US |
| June 2007 |
Grant of European patent on isobaric Tandem Mass Tags® |
| May 2007 |
Notice of intention to grant European patent for TMT2 |
| May 2007 |
Notice of Allowance of TMT1 Patent in Canada |
| January 2007 |
Biomarker patent for diagnosing stroke receives Notice of Intention to Grant in Europe |
| December 2006 |
Notice of Intention to Grant European patent for isobaric mass tags - TMT® technology |
| December 2006 |
US biomarker patent granted for diagnosing stroke |
| November 2006 |
Grant of Canadian patent on TMT® technology |
| September 2006 |
4th Stroke biomarkers Licence Agreement |
| June 2006 |
3rd Licence Agreement on Stroke biomarkers |
| May 2006 |
Stroke biomarkers licensed to BioMerieux |
| March 2006 |
Co-marketing Agreement with Medical Solutions plc |
| December 2005 |
EU Framework 6 grant award to InnoMed |
| September 2005 |
Creation of MRC Centre for Neurodegenerative Research at KCL |
| September 2005 |
Discovery of Alzheimer's biomarkers in blood |
| October 2004 |
Final Human Genome Sequence - 19,599 genes |
| May 2004 |
Discovery of novel kinases as drug targets in Alzheimer's disease |
| January 2004 |
Biomarker patent granted in US for neuroblastoma and glioma |
| November 2003 |
US biomarker patent granted for lung, breast and oesophageal cancer |
| April 2003 |
BSE biomarkers licensed to IDEXX Laboratories Inc. |
| December 2002 |
Stroke biomarkers licensed to Biosite Inc. |
| July 2002 |
Acquisition of Aventis proteomics division, Frankfurt |
| November 2001 |
Proteomics facility opened at King's College London |
| February 2001 |
Preliminary Human Genome Sequence - c. 39,000 genes |
| March 1996 |
Intronn established - SMaRTT modification of gene expression |
| October 1995 |
Admission to AIM on London Stock Exchange |
| October 1994 |
Proteome Sciences plc founded |
